Cargando…

CIAPIN1 nuclear accumulation predicts poor clinical outcome in epithelial ovarian cancer

BACKGROUND: Epithelial ovarian cancer (EOC) is an aggressive disease with poor prognosis. The expression of cytokine-induced apoptosis inhibitor 1 (CIAPIN1) correlates with the malignant progression of several cancers. However, the relationship between the subcellular localization of CIAPIN1 and cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Xiaolan, Wang, Jian, Xin, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502349/ https://www.ncbi.nlm.nih.gov/pubmed/22713669 http://dx.doi.org/10.1186/1477-7819-10-112

Ejemplares similares

CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma
por: Nymoen, Dag Andre, et al.
Publicado: (2015)

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis
por: Shi, Hai, et al.
Publicado: (2010)

Prediction of CIAPIN1 (Cytokine-Induced Apoptosis Inhibitor 1) Signaling Pathway and Its Role in Cholangiocarcinoma Metastasis
por: Truong, Son Dinh An, et al.
Publicado: (2022)

Transduced Tat-CIAPIN1 reduces the inflammatory response on LPS− and TPA-induced damages
por: Yeo, Hyeon Ji, et al.
Publicado: (2019)

MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1
por: Zheng, Jing, et al.
Publicado: (2019)

Increased expression of MMP17 predicts poor clinical outcomes in epithelial ovarian cancer patients
por: Xiao, Chao, et al.
Publicado: (2022)

Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo
por: Li, Xiaohua, et al.
Publicado: (2008)

CIAPIN1 gene silencing enhances chemosensitivity in a drug-resistant animal model in vivo
por: Wang, X.M., et al.
Publicado: (2014)

Down Regulation of CIAPIN1 Reverses Multidrug Resistance in Human Breast Cancer Cells by Inhibiting MDR1
por: Lu, Dan, et al.
Publicado: (2012)

CIAPIN1 Targeted NHE1 and ERK1/2 to Suppress NSCLC Cells' Metastasis and Predicted Good Prognosis in NSCLC Patients Receiving Pulmonectomy
por: Wang, Jian, et al.
Publicado: (2019)

Serum Levels of Cytokine-Induced Apoptosis Inhibitor 1 (CIAPIN1) as a Potential Prognostic Biomarker of Cholangiocarcinoma
por: Truong, Son Dinh An, et al.
Publicado: (2021)

Tat-CIAPIN1 protein prevents against cytokine-induced cytotoxicity in pancreatic RINm5F β-cells
por: Yeo, Hyeon Ji, et al.
Publicado: (2021)

Elevated expression of Tweety homologue 3 predicts poor clinical outcomes in ovarian cancer
por: Zhou, Junhan, et al.
Publicado: (2021)

Lipid Droplet Accumulation Independently Predicts Poor Clinical Prognosis in High-Grade Serous Ovarian Carcinoma
por: Iwahashi, Naoyuki, et al.
Publicado: (2021)

Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer
por: Xu, Yunzhao, et al.
Publicado: (2015)

Predicting IVF outcome in poor ovarian responders
por: Lebovitz, Oshrit, et al.
Publicado: (2022)

Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer
por: Ayub, Tiyasha H., et al.
Publicado: (2015)

Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer
por: Liu, Shuang, et al.
Publicado: (2018)

Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer
por: Nakao, Sari, et al.
Publicado: (2020)

Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer
por: Zhu, Cai-xia, et al.
Publicado: (2017)

Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer
por: Deng, Lu, et al.
Publicado: (2021)

Tat-CIAPIN1 Prevents Pancreatic β-Cell Death in hIAPP-Induced RINm5F Cells and T2DM Animal Model
por: Yeo, Hyeon Ji, et al.
Publicado: (2023)

Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival
por: Sun, Fei, et al.
Publicado: (2015)

VGLL3 expression is associated with macrophage infiltration and predicts poor prognosis in epithelial ovarian cancer
por: Haque, Razaul, et al.
Publicado: (2023)

ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation
por: Liu, Qun, et al.
Publicado: (2019)

Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma
por: Li, Xiqing, et al.
Publicado: (2018)

SSRI use and clinical outcomes in epithelial ovarian cancer
por: Christensen, Desiré K., et al.
Publicado: (2016)

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer
por: Sallinen, Hanna, et al.
Publicado: (2014)

Long noncoding RNA SNHG15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer
por: Qu, Chong, et al.
Publicado: (2018)

Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome
por: Hedström, E, et al.
Publicado: (2015)

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
por: Heerma van Voss, Marise R, et al.
Publicado: (2017)

Mastl overexpression is associated with epithelial to mesenchymal transition and predicts a poor clinical outcome in gastric cancer
por: Sun, Xian-Jun, et al.
Publicado: (2017)

Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers
por: Ralhan, Ranju, et al.
Publicado: (2010)

WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer
por: Kotrbová, Anna, et al.
Publicado: (2020)

Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma
por: Chiang, Ying-Cheng, et al.
Publicado: (2015)

Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients
por: Lu, Hsiao-Yun, et al.
Publicado: (2020)

PCNP promotes ovarian cancer progression by accelerating β‐catenin nuclear accumulation and triggering EMT transition
por: Dong, Pengzhen, et al.
Publicado: (2020)

PNMA5 knockdown suppresses the proliferation, invasion, and metastasis of epithelial ovarian cancer cells
por: Qiao, Haifeng, et al.
Publicado: (2020)

Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer
por: Huang, Bihui, et al.
Publicado: (2016)

Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer
por: Xie, Xiaohui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vml0t8km0mm0023fersl4jff9m